75 Years Of Galenika

CorD Recommends

Serbian Buyers Emerge as Major Players in Croatian Property Market

Historically, Slovenians have been the principal property buyers in Croatia, consistently leading in acquisitions with 3,403 properties bought last...

Oxford University to Return Stolen 500-Year-Old Hindu Saint Statue to India

Oxford University in the UK has committed to returning a centuries-old stolen Hindu saint's bronze statue to India, marking...

The Foreign Investors Council and EBRD Hosted Conference On Financial Services

The Foreign Investors Council of Serbia, in cooperation with the European Bank for Reconstruction and Development (EBRD), organised the...

Belgrade Prepares for Expo 2027 with a Focus on Play and Creativity

Belgrade is gearing up to host the Specialized Expo 2027, a global event set to captivate the world from...

European Centrist Parties Retain Majority in New EU Parliament Session

According to preliminary results from the European Parliament elections, the European People's Party (EPP), Social Democrats (S&D), and Liberals...

In the jubilee year, Galenika a.d. Belgrade records constant growth in all segments of its business. In the first half of 2020, Galenika achieved an increase in sales by 8% compared to the same period in 2019, which strengthened its second position in the Serbian pharmaceutical market.

The direct result of the new vision and business strategy resulted in additional sales growth in the region (Montenegro, Bosnia and Herzegovina, Northern Macedonia) by 14%. Three new export markets have been opened, while Galenika is actively present in 8 international markets in the EU, the Middle East and Africa, where it has increased its sales more than double.

With a strategic partnership with its sister company from Brazil – EMS, Galenika’s Institute for Research and Development continues to develop new products. The registration of 12 products is in progress, and by the end of the year, 4 new products are expected to be released on the market. Additionally, in the first half of 2020, the production of the range of its own products increased by 5% compared to the same period in 2019.

As a responsible company, Galenika successfully implements environmental protection measures and has achieved goals that are in line with the strict requirements of ISO 14001 standards. Waste generation has been reduced since the privatization and a strict waste management procedure has been applied, while CO2 emissions have been reduced by 20% and electricity use by 10%.

” We are working to further increase production and sales in the Serbian and international markets, explore innovative ways to promote our existing products and are committed to significant portfolio growth – by registering and launching five new products per year, over the next five years. Our strategic goal is the development of Galenika, while in parallel, we do not exclude the possibility of further expansion through acquisitions, “said Ricardo Vian Marques, General Manager of Galenika.

In the field of digitalization, Galenika has already entered the transformation of Industry 4.0 and Smart Manufacturing with the implementation of the Internet of Things in production. As the first company in the region, state-of-the-art advanced business process management software, SAP S4HANA in the Cloud, has been implemented, as well as an innovative Business-to-Business platform that enables customers to purchase through the latest digital experience, anytime, anywhere.

“Galenika has been the Guardian of Health for 75 years. Especially in times like these, we see how important that is. We are proud of the 75-year tradition of the company and incomparable expertise, but at the same time in Galenika I see people who are 100% focused on the future. That is why I have great confidence in our local team and Galenika becoming a regional leader “, Marques concluded.

Related Articles

Galenika Strengthens Market Position with New Strategic Partnerships

Galenika has significantly expanded its presence in the pharmaceutical sector by securing an exclusive distribution agreement with Cantabria Labs, a leading Spanish dermatological brand....

Ricardo Vian Marques, General Manager, Galenika

Focus On Quality And Growth Drivers

Despite the challenges of global circumstances in 2023, Galenika successfully ensured the production and distribution of its products to all markets where it operates....


Pillar Of Support To Domestic And European Farmers

With 16 registered products that are harmonised with European legislations, phytopharmaceuticals company Galenika-Fitofarmacija a.d. (JSC) is present on 28 markets, 19 of which are...

Carlos Puglia, Galenika Executive Director For Sales And Marketing

We Are Ready For Global Goals

As part of Grupo NC, one of the largest conglomerates in Brazil, Galenika is a company that operates on the global market. Its focus...

Milorad Ilić, Galenika

Pharmaceutical Operations In The EU

Over the course of the previous three years, Galenika has undergone an intensive period of investment and transformation, thanks to which it has repositioned...

Ljiljana Topić, Director, Galenika Pharmacia

Nurturing It’s Own Leadership Position

Galenika Pharmacia produces more than 50 different medical devices - sterile and non-sterile compresses, plaster strips, bandaid plasters, bandages and sanitary materials, vehicle first...

Ricardo Vian Marques, General Manager, Galenika a.d. Beograd

Future-Orientated Company

Over the course of 2020, Galenika continued its trend from the previous year by growing faster than the market, more than 50% faster. It...

Ljiljana Topić, Director, Galenika Pharmacia

We’re Here When Times Are Hardest

Galenika Pharmacia is a factory that produces complete sanitary consumables – from compresses, gauzes and bandages, via disinfectants, to surgical masks that have become...